SYS-CON MEDIA Authors: Gilad Parann-Nissany, Unitiv Blog, Kevin Benedict, Maxime Charlès, RealWire News Distribution

News Feed Item

Theratechnologies Resumes Shipment of Tesamorelin to EMD Serono

MONTREAL, CANADA -- (Marketwired) -- 12/03/13 -- Theratechnologies Inc. (TSX: TH) is pleased to announce that it has resumed shipment of EGRIFTA™ (tesamorelin for injection) to EMD Serono in the United States today.

Moreover, Jubilant HollisterStier, the third-party contract manufacturer for tesamorelin, also informed Theratechnologies that the strike, which was initiated by employees working at its manufacturing site in Montreal, Canada, is now over.

About Theratechnologies

Theratechnologies (TSX: TH) is a biopharmaceutical company that specializes in innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. Further information about Theratechnologies is available on the Company's website at, on SEDAR at and on the Securities and Exchange Commission's website at

Denis Boucher
NATIONAL Public Relations

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.